Examination Report |
1 | Other Documents | 17 Feb 2009 |
10 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 14 Jul 2023 |
11 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 12 Dec 2023 |
12 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 11 Apr 2024 |
13 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 18 Apr 2024 |
14 | Annexure -1 under rule 46 | 01 Aug 2024 |
14 | Evidence Affidavit Under Rule 46 (TOP) | 01 Aug 2024 |
15 | Annexure -1 under rule 46 | 01 Aug 2024 |
15 | Evidence Affidavit Under Rule 46 (TOP) | 01 Aug 2024 |
16 | Evidence Affidavit Under Rule 46 (TOP) | 01 Aug 2024 |
17 | Annexure -1 under rule 46 | 01 Aug 2024 |
2 | TM-1 | 17 Feb 2009 |
3 | TM-16 | 08 Feb 2017 |
4 | Correspondence | 15 Mar 2017 |
5 | TM-M(REQUEST FOR THE INSPECTION OF THE DOCUMENT UNDER RULE 121) | 28 Jan 2020 |
6 | Letters related to TOP | 13 Feb 2020 |
7 | Letters related to TOP | 13 Feb 2020 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 21 Dec 2022 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 13 Jun 2023 |
The application for Zolephos was made on 17 February 2009.
The trademark applicant for Zolephos is ABBOTT HEALTHCARE.
Zolephos is applied in class(es) 5.
Application for Zolephos is on Opposed stage.
Application Id allotted to Zolephos is 1786280.
Trademark agent or attorney for the application is Zeusip.
Zolephos filed with the Intellectual property office as a WORD.